NADAL – BioCIS

Simon Nadal

Chercheur

Junior Group Leader

CDD, Chimie Biologique

simon.nadal@cyu.fr

Site de Cergy

CDD

https://orcid.org/0000-0002-0748-0284

Chemical biology

Proteomics

Protein chemistry

Multiple Myeloma

5 documents

Articles dans une revue5 document

Lorenzo Meneghelli, Stephanie Davidson, Anthony Gineste, Lamia El Guermah, Sabrina Kellouche-Gaillard, et al.. Design and synthesis of a clickable cell-permeable pseudopeptide Pin1 inhibitor with antiproliferative effects on human multiple myeloma cell line. Chemical Communications, 2025, ⟨10.1039/D4CC05968A⟩. ⟨hal-05003977⟩
Pieter Langerhorst, Melissa Baerenfaenger, Purva Kulkarni, Simon Nadal, Charissa Wijnands, et al.. N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma. Clinical Chemistry and Laboratory Medicine, 2024, 62 (8), pp.1626-1635. ⟨10.1515/cclm-2023-1189⟩. ⟨hal-05085563⟩
Severin Lechner, Martin Ian P. Malgapo, Christian Grätz, Raphael Steimbach, Agnes Baron, et al.. Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target. Nature Chemical Biology, 2022, 18 (8), pp.812-820. ⟨10.1038/s41589-022-01015-5⟩. ⟨hal-05085539⟩
Brian Josephson, Charlie Fehl, Patrick Isenegger, Simon Nadal, Tom Wright, et al.. Light-driven post-translational installation of reactive protein side chains. Nature, 2020, 585 (7826), pp.530-537. ⟨10.1038/s41586-020-2733-7⟩. ⟨hal-05085267⟩
Simon Nadal, Ritu Raj, Shabaz Mohammed, Benjamin Davis. Synthetic post-translational modification of histones. Current Opinion in Chemical Biology, 2018, 45, pp.35-47. ⟨10.1016/j.cbpa.2018.02.004⟩. ⟨hal-05085237⟩